Soligenix, Inc. (SNGX) stock
SNGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.28−0.01 (-2.67%)
Close on Nov 17, 2026Market cap $6.11MP/E –Yield –
Soligenix cash
Cash and short-term investments held at the end of each period.
Soligenix's cash was $9.81M at Jun 30, 2026. For fiscal 2025 it was $7.94M, up 1.5% from the year before. Over ten years it grew 4.9% a year on average. The highest annual figure on record is $26.04M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.94M | +1.5% |
| FY2024 | Dec 31, 2024 | $7.82M | -7.4% |
| FY2023 | Dec 31, 2023 | $8.45M | -36.8% |
| FY2022 | Dec 31, 2022 | $13.36M | -48.7% |
| FY2021 | Dec 31, 2021 | $26.04M | +39.4% |
| FY2020 | Dec 31, 2020 | $18.68M | +244.5% |
| FY2019 | Dec 31, 2019 | $5.42M | -39.7% |
| FY2018 | Dec 31, 2018 | $8.98M | +15.0% |
| FY2017 | Dec 31, 2017 | $7.81M | -11.0% |
| FY2016 | Dec 31, 2016 | $8.77M | +78.2% |
| FY2015 | Dec 31, 2015 | $4.92M | -10.9% |
| FY2014 | Dec 31, 2014 | $5.53M | -5.7% |
| FY2013 | Dec 31, 2013 | $5.86M | +74.5% |
| FY2012 | Dec 31, 2012 | $3.36M | -44.0% |
| FY2011 | Dec 31, 2011 | $6.00M | -19.5% |
| FY2010 | Dec 31, 2010 | $7.45M | -3.1% |
| FY2009 | Dec 31, 2009 | $7.69M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $9.81M | +92.5% |
| Q1 FY2026 | Mar 31, 2026 | $6.03M | -17.4% |
| Q4 FY2025 | Dec 31, 2025 | $7.94M | +1.5% |
| Q3 FY2025 | Sep 30, 2025 | $10.53M | +7.0% |
| Q2 FY2025 | Jun 30, 2025 | $5.10M | -45.8% |
| Q1 FY2025 | Mar 31, 2025 | $7.30M | +2.9% |
| Q4 FY2024 | Dec 31, 2024 | $7.82M | -7.4% |
| Q3 FY2024 | Sep 30, 2024 | $9.84M | -4.5% |
| Q2 FY2024 | Jun 30, 2024 | $9.41M | -28.5% |
| Q1 FY2024 | Mar 31, 2024 | $7.09M | -30.9% |
| Q4 FY2023 | Dec 31, 2023 | $8.45M | -36.8% |
| Q3 FY2023 | Sep 30, 2023 | $10.30M | -38.9% |
| Q2 FY2023 | Jun 30, 2023 | $13.16M | -34.7% |
| Q1 FY2023 | Mar 31, 2023 | $10.27M | -55.1% |
| Q4 FY2022 | Dec 31, 2022 | $13.36M | -48.7% |
| Q3 FY2022 | Sep 30, 2022 | $16.87M | -41.6% |
| Q2 FY2022 | Jun 30, 2022 | $20.16M | -30.4% |
| Q1 FY2022 | Mar 31, 2022 | $22.88M | -25.1% |
| Q4 FY2021 | Dec 31, 2021 | $26.04M | +39.4% |
| Q3 FY2021 | Sep 30, 2021 | $28.87M | +154.5% |
| Q2 FY2021 | Jun 30, 2021 | $28.98M | +159.5% |
| Q1 FY2021 | Mar 31, 2021 | $30.54M | +324.0% |
| Q4 FY2020 | Dec 31, 2020 | $18.68M | +244.5% |
| Q3 FY2020 | Sep 30, 2020 | $11.34M | +57.5% |
| Q2 FY2020 | Jun 30, 2020 | $11.17M | +24.3% |
| Q1 FY2020 | Mar 31, 2020 | $7.20M | -38.5% |
| Q4 FY2019 | Dec 31, 2019 | $5.42M | +27.7% |
| Q1 FY2019 | Mar 31, 2019 | $7.20M | +13.1% |
| Q4 FY2018 | Dec 31, 2018 | $8.98M | +15.0% |
| Q3 FY2018 | Sep 30, 2018 | $11.72M | +134.4% |
| Q2 FY2018 | Jun 30, 2018 | $4.24M | -27.0% |
| Q1 FY2018 | Mar 31, 2018 | $6.37M | -10.9% |
| Q4 FY2017 | Dec 31, 2017 | $7.81M | -11.0% |
| Q3 FY2017 | Sep 30, 2017 | $5.00M | -11.6% |
| Q2 FY2017 | Jun 30, 2017 | $5.81M | +82.6% |
| Q1 FY2017 | Mar 31, 2017 | $7.14M | +67.7% |
| Q4 FY2016 | Dec 31, 2016 | $8.77M | – |
| Q3 FY2016 | Sep 30, 2016 | $5.66M | – |
| Q2 FY2016 | Jun 30, 2016 | $3.18M | – |
| Q1 FY2016 | Mar 31, 2016 | $4.26M | – |
See a number that looks wrong?